The role of passive immunization in the age of SARS-CoV-2: an update
Johannes Fischer, Kurt S. Zänker, Martijn van Griensven, Marion Schneider, Detlef Kindgen‐Milles, Wolfram Trudo Knoefel, Artur Lichtenberg, Bálint Tamaskovics, Freddy Joel Djiepmo-Njanang, Wilfried Budach, Stefanie Corradini, Ute Ganswindt, Dieter Häussinger, Torsten Feldt, Hubert Schelzig, Hans Bojar, Matthias Peiper, Edwin Bölke, Jan Haussmann, Christiane Matuschek
Abstract
The rapid spread of the corona virus pandemic is an existential problem for many people in numerous countries. So far, there is no effective vaccine protection or proven therapy available against the SARS-CoV-2 virus. In this review, we describe the role of passive immunization in times of the corona virus. Passive immunization could be a bridging technology to improve the immune defense of critically ill patients until better approaches with effective medications are available.